Literature DB >> 15712660

Effect of ursodeoxycholic acid on granulomatous liver disease due to sarcoidosis.

Bader Alenezi1, Esther Lamoureux, Lesley Alpert, Andrew Szilagyi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15712660     DOI： 10.1007/s10620-005-1300-2

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  21 in total

1.  The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis.

Authors:  C Corpechot; F Carrat; A M Bonnand; R E Poupon; R Poupon
Journal:  Hepatology       Date:  2000-12       Impact factor: 17.425

2.  Chronic intrahepatic cholestasis of sarcoidosis.

Authors:  C Rudzki; K G Ishak; H J Zimmerman
Journal:  Am J Med       Date:  1975-09       Impact factor: 4.965

3.  Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis.

Authors:  Renée Eugénie Poupon; Keith D Lindor; Albert Parés; Olivier Chazouillères; Raoul Poupon; E Jenny Heathcote
Journal:  J Hepatol       Date:  2003-07       Impact factor: 25.083

Review 4.  Sarcoidosis of the liver and bile ducts.

Authors:  K G Ishak
Journal:  Mayo Clin Proc       Date:  1998-05       Impact factor: 7.616

5.  Effect of ursodeoxycholic acid on chronic intrahepatic cholestasis due to sarcoidosis.

Authors:  H Bécheur; H Dall'osto; G Chatellier; M C Charton-Bain; J M Aubertin; A Attar; F Bloch; J P Petite
Journal:  Dig Dis Sci       Date:  1997-04       Impact factor: 3.199

Review 6.  Sarcoidosis.

Authors:  L S Newman; C S Rose; L A Maier
Journal:  N Engl J Med       Date:  1997-04-24       Impact factor: 91.245

Review 7.  Hepatic sarcoidosis responding to chloroquine as steroid-sparing drug.

Authors:  S Galwankar; M Vyas; D Desai; Z F Udwadia
Journal:  Indian J Gastroenterol       Date:  1999 Oct-Nov

8.  Ursodeoxycholic acid delays the onset of esophageal varices in primary biliary cirrhosis.

Authors:  K D Lindor; R A Jorgensen; T M Therneau; M Malinchoc; E R Dickson
Journal:  Mayo Clin Proc       Date:  1997-12       Impact factor: 7.616

Review 9.  Extrapulmonary sarcoidosis primarily diagnosed in the liver.

Authors:  S Mueller; M W Boehme; W J Hofmann; W Stremmel
Journal:  Scand J Gastroenterol       Date:  2000-09       Impact factor: 2.423

Review 10.  Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited.

Authors:  Gustav Paumgartner; Ulrich Beuers
Journal:  Hepatology       Date:  2002-09       Impact factor: 17.425
View more
  5 in total

Review 1.  Extrapulmonary manifestations of sarcoidosis.

Authors:  Deepak A Rao; Paul F Dellaripa
Journal:  Rheum Dis Clin North Am       Date:  2013-03-13       Impact factor: 2.670

Review 2.  Granulomatous liver disease.

Authors:  Sidharth S Bhardwaj; Romil Saxena; Paul Y Kwo
Journal:  Curr Gastroenterol Rep       Date:  2009-02

3.  Diagnosis and treatment of hepatic sarcoidosis.

Authors:  Uma S Ayyala; Maria L Padilla
Journal:  Curr Treat Options Gastroenterol       Date:  2006

Review 4.  Systemic causes of cholestasis.

Authors:  Andrew S Delemos; Lawrence S Friedman
Journal:  Clin Liver Dis       Date:  2013-01-26       Impact factor: 6.126

Review 5.  Management of extrapulmonary sarcoidosis: challenges and solutions.

Authors:  Khalid Al-Kofahi; Peter Korsten; Christian Ascoli; Shanti Virupannavar; Mehdi Mirsaeidi; Ian Chang; Naim Qaqish; Lesley A Saketkoo; Robert P Baughman; Nadera J Sweiss
Journal:  Ther Clin Risk Manag       Date:  2016-11-07       Impact factor: 2.423
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.